Mylan Shareholders OK Tender As Perrigo Draws Irish Regulators’ Rebuke
This article was originally published in The Pink Sheet Daily
Executive Summary
Rx generics and specialty products manufacturer Mylan receives approval of two-thirds of votes cast at a shareholder meeting to tender an offer directly to Perrigo shareholders. Market analysts doubted Mylan’s chances with its shareholders and remain pessimistic about the tender for Perrigo.